TMCI:NASDAQ
Treace Medical Concepts, Inc
$5.27
arrow_downward
-1.31%(-0.070) 1D
$5.29
arrow_upward
+0.38% (+0.020)todayPre-market
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
$5.32
High
$5.32
Low
$4.95
Mkt. cap
345.50M
Avg. vol.
294.14K
Volume
137.00
52-wk high
$5.44
52-wk low
$1.17
EPS
-$0.86
Beta
1.59
Shares outstanding
65.56M
No. of employees
450
Open
$5.32
High
$5.32
Low
$4.95
Mkt. cap
345.50M
Avg. vol.
294.14K
Volume
137.00
52-wk high
$5.44
52-wk low
$1.17
EPS
-$0.86
Beta
1.59
Shares outstanding
65.56M
No. of employees
450
News stories
From web sources and news partners
Cryptonews.net
·
42 minutes ago
Drakewell Introduces Hedged S&P 500 Token
US News Money
·
1 hour ago
S&P 500, Nasdaq Futures Slide as Nvidia Earnings, Anthropic Debut Loom
Business Insider
·
2 hours ago
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
Traders Union
·
21 minutes ago
Caleb Franzen: S&P 500 futures fall 0.13% as Bitcoin futures drop 5.56%
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc